Dec 23 (Reuters) - Recce Pharmaceuticals Ltd RCE.AX :
* RECCE® 327, RECCE® 529 DEMONSTRATED DOSE-DEPENDENT ACTIVITY IN-VIVO AGAINST SARS-COV-2 VIRUS IN SYRIAN GOLDEN HAMSTERS
Dec 23 (Reuters) - Recce Pharmaceuticals Ltd RCE.AX :
* RECCE® 327, RECCE® 529 DEMONSTRATED DOSE-DEPENDENT ACTIVITY IN-VIVO AGAINST SARS-COV-2 VIRUS IN SYRIAN GOLDEN HAMSTERS